CIT can broadcast your seminar, conference or meeting live to a world-wide
audience over the Internet as a real-time streaming video. The event can
be recorded and made available for viewers to watch at their convenience
as an on-demand video or a downloadable podcast. CIT can also broadcast
NIH-only or HHS-only content.
Translational Research Interest Group
Dr. John Gallin will provide an overview of translational research at the NIH Clinical Center, providing an emphasis on current activities and looking ahead to future opportunities. The Clinical Center serves to support NIH clinical research at all points along the continuum: from the laboratory to the patient and back to the bench; and, within the Clinical Center, many exciting research discoveries have been made. Dr. Gallin’s talk will also include background on the Bench-to-Bedside (B2B) Program, which began in 1999 and expanded five years ago to include extramural collaborators. The B2B Program is a successful model for promoting exciting translational clinical research projects. Dr. Gallin’s lecture will set the stage for future Translational Research Interest Group lecturers who are B2B awardees with success stories to share with the NIH community.
The pipeline of clinical research from bench to bedside and back [electronic resource] / John Gallin.
Author:
Gallin, John I. National Institutes of Health (U.S.). Translational Research Interest Group.
Publisher:
[Bethesda, Md. : National Institutes of Health, 2010]
Abstract:
(CIT): Translational Research Interest Group Dr. John Gallin will provide an overview of translational research at the NIH Clinical Center, providing an emphasis on current activities and looking ahead to future opportunities. The Clinical Center serves to support NIH clinical research at all points along the continuum: from the laboratory to the patient and back to the bench; and, within the Clinical Center, many exciting research discoveries have been made. Dr. Gallin"s talk will also include background on the Bench-to-Bedside (B2B) Program, which began in 1999 and expanded five years ago to include extramural collaborators. The B2B Program is a successful model for promoting exciting translational clinical research projects. Dr. Gallin"s lecture will set the stage for future Translational Research Interest Group lecturers who are B2B awardees with success stories to share with the NIH community. http://sigs.nih.gov/trig.
Subjects:
Academies and Institutes Translational Medical Research United States Government Agencies United States
